is part of the Global Exhibitions Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
A leader in medical imaging technology for over 35 years and currently selling products to 131 counties, Ampronix develops, distributes, and services groundbreaking solutions that promote optimal patient outcome. Ampronix has been exhibiting at FIME for the past 15 years, says Nelson Fathollahi, CEO of Ampronix Medical Imaging Technology, “and our main objective is to introduce our medical imaging technology to the North, Central, South, and Latin American medical communities.”
He believes that technology advancements are driving the healthcare industry forward and that by “bringing product knowledge and customers together such as what is taking place at FIME really allows for positive collaboration and continued growth.”
What do you think is currently driving the healthcare industry forward, in both the Latin American and the US market?
I believe technology advancements are driving the healthcare industry forward alongside products being more readily available.
What current trends do you see specifically in both the Latin American and the US healthcare industry and what do you see as the growth areas going forward?
We are noticing that healthcare facilities are spending more time on upgrading their legacy equipment and replacing that equipment with the latest new equipment that is available.
What, according to you, are the main ideas/strategies that will transform the healthcare industry of the future
Bringing product knowledge and customers together such as what is taking place at FIME really allows for positive collaboration and continued growth.
How important is innovation in healthcare? What are the technological, medical and strategic innovations that your company brings to the healthcare and / or medical laboratory arena?
Innovation is very important because every new technology advancement that is created can directly impact patients’ lives.
What is your plan for FIME 2018?
A. What products, solutions or technology will you be showcasing?
This year at FIME we are partnering with LG Business Solutions and displaying their latest 8MP Clinical and Surgical displays. We will also be showcasing a Universal Modality Replacement CRT to Flat Panel LED displays as well as an OEC Upgrade Kit.
B. What is unique or new about your product or service?
Being in business for over 35 years and currently selling products to 131 counties has allowed us to receive direct feedback from Biomeds and customers alike. If they run into an issue and a product is not currently available to give them a solution we have an in-house research and development centre where we are able to create products to facilitate their concerns. We have done this with our MODALIXX displays which are currently programed with over 5,000 parameters to allow the display to sync up with pre-existing modalities. We are able to convert legacy CRT displays that are still being used in Cath Labs and are able convert those to Flat Panel LED displays. This solution has been very effective for both the Latin American and US markets. Additionally, we have a Full Service & Repair facility that allows us to repair medical equipment such as Ultrasound Machines, Printers, Projectors, Medical Displays, Recorders, and Patient Monitors.
As a company closely associated with FIME for the past several years, how would you evaluate the impact of the event on the healthcare industry in the Latin American and the US market?
Ampronix’s participation at FIME is highly beneficial. At FIME, we have the ability to meet with new companies and representatives that are interested in our products and services, from all around the world especially in Latin America and US markets.
How has FIME aided your company’s yearly strategy in developing business opportunities in Latin American and the US markets?
Latin America and US markets are very important for our continued growth. A majority of our business is within these markets and we value the opportunity to exhibit at FIME tradeshow every year because it helps us to brings all of these markets together.
What, according to you, are the real benefits and opportunities available to healthcare and trade professionals in attending FIME?
Ampronix has been exhibiting at FIME for the past 15 years and our main objective is to introduce our medical imaging technology to the North, Central, South, and Latin American medical communities. In addition, the real benefits and opportunity for attending the FIME show is to connect with new potential customers in our industry. We also look forward to meeting some of our long-time customers who will also be attending FIME.